Efficacy and Safety of Nonantibiotic Outpatient Treatment in Mild Acute Diverticulitis (DINAMO-study)

医学 急诊科 临床终点 阿莫西林 克拉维酸 抗生素 置信区间 随机对照试验 内科学 门诊部 前瞻性队列研究 外科 生物 微生物学 精神科
作者
Laura Mora-López,Neus Ruiz-Edo,Oscar Estrada-Ferrer,Maria Luisa Piñana-Campón,Meritxell Labró-Ciurans,Jordi Escuder-Perez,Ricard Sales-Mallafré,Pere Rebasa-Cladera,Salvador Navarro‐Soto,Xavier Serra‐Aracil
出处
期刊:Annals of Surgery [Lippincott Williams & Wilkins]
卷期号:274 (5): e435-e442 被引量:25
标识
DOI:10.1097/sla.0000000000005031
摘要

Mild AD can be treated safely and effectively on an outpatient basis without antibiotics.In recent years, it has shown no benefit of antibiotics in the treatment of uncomplicated AD in hospitalized patients. Also, outpatient treatment of uncomplicated AD has been shown to be safe and effective.A Prospective, multicentre, open-label, noninferiority, randomized controlled trial, in 15 hospitals of patients consulting the emergency department with symptoms compatible with AD.The Participants were patients with mild AD diagnosed by Computed Tomography meeting the inclusion criteria were randomly assigned to control arm (ATB-Group): classical treatment (875/125 mg/8 h amoxicillin/clavulanic acid apart from anti-inflammatory and symptomatic treatment) or experimental arm (Non-ATB-Group): experimental treatment (antiinflammatory and symptomatic treatment). Clinical controls were performed at 2, 7, 30, and 90 days.The primary endpoint was hospital admission. Secondary endpoints included number of emergency department revisits, pain control and emergency surgery in the different arms.Four hundred and eighty patients meeting the inclusion criteria were randomly assigned to Non-ATB-Group (n = 242) or ATB-Group (n = 238). Hospitalization rates were: ATB-Group 14/238 (5.8%) and Non-ATB-Group 8/242 (3.3%) [mean difference 2.58%, 95% confidence interval (CI) 6.32 to -1.17], confirming noninferiority margin. Revisits: ATB-Group 16/238 (6.7%) and Non-ATB-Group 17/242 (7%) (mean difference -0.3, 95% CI 4.22 to -4.83). Poor pain control at 2 days follow up: ATB-Group 13/230 (5.7%), Non-ATB-Group 5/221 (2.3%) (mean difference 3.39, 95% CI 6.96 to -0.18).Nonantibiotic outpatient treatment of mild AD is safe and effective and is not inferior to current standard treatment.ClinicalTrials.gov (NCT02785549); EU Clinical Trials Register (2016-001596-75).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
爆米花应助ZZZ采纳,获得10
刚刚
quhayley应助生动的翠容采纳,获得10
刚刚
大美女完成签到,获得积分10
刚刚
ning完成签到,获得积分10
刚刚
干净问筠发布了新的文献求助10
1秒前
袁小圆发布了新的文献求助30
1秒前
樊夏岚完成签到,获得积分10
1秒前
1秒前
1秒前
西门放狗发布了新的文献求助10
2秒前
玛卡巴卡完成签到,获得积分10
2秒前
2秒前
yggggg发布了新的文献求助10
3秒前
爱笑秀发完成签到,获得积分20
3秒前
3秒前
3秒前
卢小白完成签到,获得积分10
3秒前
henry完成签到 ,获得积分10
3秒前
我我我完成签到,获得积分10
4秒前
开放的扬完成签到 ,获得积分10
4秒前
4秒前
义气猫咪发布了新的文献求助30
4秒前
dhts应助czj采纳,获得10
4秒前
4秒前
5秒前
小魏小魏完成签到,获得积分10
5秒前
韩哈哈发布了新的文献求助10
5秒前
化学完成签到,获得积分10
6秒前
ding应助yggggg采纳,获得10
6秒前
7秒前
7秒前
yao发布了新的文献求助10
7秒前
123完成签到,获得积分10
8秒前
Juliannahe完成签到,获得积分10
8秒前
文静元风发布了新的文献求助10
8秒前
Li发布了新的文献求助10
8秒前
化学发布了新的文献求助10
8秒前
9秒前
学习中完成签到,获得积分10
9秒前
9秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
A new approach to the extrapolation of accelerated life test data 500
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3953748
求助须知:如何正确求助?哪些是违规求助? 3499604
关于积分的说明 11096363
捐赠科研通 3230143
什么是DOI,文献DOI怎么找? 1785894
邀请新用户注册赠送积分活动 869656
科研通“疑难数据库(出版商)”最低求助积分说明 801498